Platelet activation by heparin

Blood

Volumn 117, Issue 18, 2011, Pages 4686-4687

  Greinacher, Andreas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; FOCAL ADHESION KINASE; FONDAPARINUX; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANTICOAGULATION; COMPLEX FORMATION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

EID: 79955948134     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-03-341677     Document Type: Note

References (6)

1. Gao C, Boylan B, Fang J, Wilcox DA, Newman DK, Newman PJ. Heparin promotes platelet responsiveness by potentiating alphaIIbbeta3-mediated outside-in signaling. Blood. 2011;117(18):4946-4952.
2. Horne MK III. Nonimmune heparin-platelet interactions: Implications for the pathogenesis of heparin-induced thrombocytopenia. In: Warkentin TE and Greinacher A, eds. Heparin-induced thrombocytopenia (4th ed). New York; Informa Health Care: 2007,117-130.
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79(1):1-7. (Pubitemid 28037046)
4. Chong BH, Ismail F. The mechanism of heparin-induced platelet aggregation. Eur J Haematol. 1989;43(3):245-251. (Pubitemid 19252208)
5. Barradas MA, Mikhailidis DP, Epemolu O, Jeremy JY, Fonseca V, Dandona P. Comparison of the platelet proaggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222). Br J Haematol. 1987;67(4):451-457. (Pubitemid 18032044)
6. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003;289(7):853-863. (Pubitemid 37430344)